These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29529229)

  • 1. Present developments in reaching an international consensus for a model-based approach to particle beam therapy.
    Prayongrat A; Umegaki K; van der Schaaf A; Koong AC; Lin SH; Whitaker T; McNutt T; Matsufuji N; Graves E; Mizuta M; Ogawa K; Date H; Moriwaki K; Ito YM; Kobashi K; Dekura Y; Shimizu S; Shirato H
    J Radiat Res; 2018 Mar; 59(suppl_1):i72-i76. PubMed ID: 29529229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
    Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.
    Kobashi K; Prayongrat A; Kimoto T; Toramatsu C; Dekura Y; Katoh N; Shimizu S; Ito YM; Shirato H
    J Radiat Res; 2018 Mar; 59(suppl_1):i50-i57. PubMed ID: 29538699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review.
    Murayama S; Yamada S; Hiroshima Y; Takiyama H; Taguchi H; Kimoto T; Anzai M; Hagiwara Y; Yasui K; Mori K; Ishihara S; Ueno H; Shimizu S; Aoyama H; Tsuji H; Sakurai H
    J Radiat Res; 2023 Jun; 64(Supplement_1):i25-i33. PubMed ID: 37117038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
    Mishra MV; Aggarwal S; Bentzen SM; Knight N; Mehta MP; Regine WF
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):228-235. PubMed ID: 28068231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical Modelling for Patient Selection in Proton Therapy.
    Mee T; Kirkby NF; Kirkby KJ
    Clin Oncol (R Coll Radiol); 2018 May; 30(5):299-306. PubMed ID: 29452724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of meningioma and glioma with protons and carbon ions.
    Adeberg S; Harrabi SB; Verma V; Bernhardt D; Grau N; Debus J; Rieken S
    Radiat Oncol; 2017 Dec; 12(1):193. PubMed ID: 29195506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy.
    Bijman RG; Breedveld S; Arts T; Astreinidou E; de Jong MA; Granton PV; Petit SF; Hoogeman MS
    Acta Oncol; 2017 Nov; 56(11):1444-1450. PubMed ID: 28828923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.
    Ojerholm E; Kirk ML; Thompson RF; Zhai H; Metz JM; Both S; Ben-Josef E; Plastaras JP
    Acta Oncol; 2015; 54(8):1209-17. PubMed ID: 25734796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling of late side-effects following cranial proton beam therapy.
    Dutz A; Lühr A; Agolli L; Bütof R; Valentini C; Troost EGC; Baumann M; Vermeren X; Geismar D; Lamba N; Lebow ES; Bussière M; Daly JE; Bussière MR; Krause M; Timmermann B; Shih HA; Löck S
    Radiother Oncol; 2021 Apr; 157():15-23. PubMed ID: 33482232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Particle beam radiotherapy].
    Saitoh J; Nakano T
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2546-9. PubMed ID: 25596047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton-beam therapy for prostate cancer.
    Kagan AR; Schulz RJ
    Cancer J; 2010; 16(5):405-9. PubMed ID: 20890135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commissioning and quality assurance of an integrated system for patient positioning and setup verification in particle therapy.
    Pella A; Riboldi M; Tagaste B; Bianculli D; Desplanques M; Fontana G; Cerveri P; Seregni M; Fattori G; Orecchia R; Baroni G
    Technol Cancer Res Treat; 2014 Aug; 13(4):303-14. PubMed ID: 24206209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of carbon beam therapy: biophysical models of carbon beam therapy.
    Matsufuji N
    J Radiat Res; 2018 Mar; 59(suppl_1):i58-i62. PubMed ID: 29528425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced radiation therapy project for cancer treatment--from Hokkaido to the world, the world access to Hokkaido].
    Shimizu S; Tsuchiya K; Takao S; Shirato H
    Hokkaido Igaku Zasshi; 2014 May; 89(1):25-8. PubMed ID: 25000814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Canadian consensus recommendations for proton beam therapy access in Canada.
    Mitera G; Tsang D; McCurdy B; Goddard K; Ebacher A; Craig T; Greenland J; Kentish S; Koul R; Logie N; Morneau M; Morrison A; Pan L; Pantarotto J; Foxcroft S; Sussman J; Thompson R; Tyldesley S; Wright P; Hicks S; Brown E; Patel S;
    Radiother Oncol; 2022 Nov; 176():228-233. PubMed ID: 36228758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Beam Therapy - the Challenges of Delivering High-quality Evidence of Clinical Benefit.
    National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Proton Beam Clinical Trial Strategy Group
    Clin Oncol (R Coll Radiol); 2018 May; 30(5):280-284. PubMed ID: 29551566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.